Pulse Biosciences
Pre-clinicalPulse Biosciences pioneers in the research, design and production of our patented nPulse™ technology for use in high impact areas of healthcare. We are currently focused on applying our proprietary nPulse technology for the ablation of soft tissue and related applications, such as the ablation of benign thyroid tumors and nodules as well as ablations to restore normal cardiac sinus rhythm such as atrial fibrillation.
About
Pulse Biosciences pioneers in the research, design and production of our patented nPulse™ technology for use in high impact areas of healthcare. We are currently focused on applying our proprietary nPulse technology for the ablation of soft tissue and related applications, such as the ablation of benign thyroid tumors and nodules as well as ablations to restore normal cardiac sinus rhythm such as atrial fibrillation.
Funding History
2Total raised: $65M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile